Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of calycosin to preparation of drugs for preventing, relieving and/or treating hyperuricemia

A technology of calycosin and hyperuricemia, which is applied in the field of medicine, can solve the problems of limited treatment effect of hyperuricemia, achieve the effect of alleviating liver atrophy and significant curative effect

Pending Publication Date: 2020-05-29
CHINA PHARM UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

As a result, Fangji Huangqi Decoction has limited therapeutic effect on hyperuricemia, and there are certain individual differences

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of calycosin to preparation of drugs for preventing, relieving and/or treating hyperuricemia
  • Application of calycosin to preparation of drugs for preventing, relieving and/or treating hyperuricemia
  • Application of calycosin to preparation of drugs for preventing, relieving and/or treating hyperuricemia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0040] The following embodiments may enable those skilled in the art to understand the present invention more comprehensively, but do not limit the present invention in any way. If specific conditions are not indicated in the examples, it shall be carried out in accordance with conventional conditions or conditions recommended by the manufacturer. The reagents or instruments used without the manufacturer's indication are all conventional products that can be purchased commercially.

[0041] Experimental animals: Kunming mice, SPF grade 20±2g, male.

[0042] Experimental drugs: potassium oxazinate (brand: aladdin, product number: P137112), allopurinol (brand: aladdin, product number: A105386), verbasil (Shanghai Shifeng Biological Products Co., Ltd.), fangchi, astragalus, licorice, Atractylodes.

[0043] Experimental model: mouse hyperuricemia model.

[0044] Experimental method: Kunming mice were randomly divided into groups and numbered, each with 7 mice, namely the normal group, t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of medicine, and aims at exploring an active compound for treating hyperuricemia. Experimental researches find that calycosin has certain treating effect for hyperuricemia. The medicinal composition is definitely a monomeric compound; and meanwhile, animal experiments indicate that the compound has a relatively strong function of reducing the contents of uric acid (UA), blood urea nitrogen (BUN), creatinine (SCr) and xanthine oxidase (XOD) in mice. Hyperuricemia animal models are utilized to prove that calycosin is remarkable in effect of treating hyperuricemia.

Description

Technical field [0001] The invention relates to the field of medical technology, and to be precise, the application of mullein, especially the application in the treatment of hyperuricemia. Background technique [0002] Hyperuricemia is a metabolic disease in which uric acid production increases and excretion decreases due to the disorder of purine metabolism. This disease is easy to precipitate and deposit urate crystals in the body, leading to gout, and inducing many major diseases such as myocardial infarction, coronary heart disease, diabetes, hyperlipidemia, metabolic syndrome and chronic kidney disease. [0003] my country’s economy is developing rapidly, and people’s eating habits have also changed dramatically. The number of patients with hyperuricemia caused by poor eating habits is also increasing year by year. According to reports, there are about 120 million patients suffering from hyperuricemia in my country, accounting for about 10% of the total number of people in m...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/352A61P19/06
CPCA61K31/352A61P19/06
Inventor 黄金王超南张荩元王星黄婉婷陶泽鑫潘越
Owner CHINA PHARM UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com